References
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81.
- Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JPA. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
- Eyles DW, Berne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013;34:47–64.
- Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry 2014;19:444–51.
- Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly US population. J Gerontol A Biol Sci Med Sci 2011;66:59–65.
- Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009;16:1083–9.
- Belvederi Murri M, Respino M, Masotti M, Innamorati M, Mondelli V, Pariante C, et al. Vitamin D and psychosis: min meta-analysis. Schizophr Res 2013;150:235–9.
- Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab 2014;99:3863–72.
- Schwartz PJ. Season of birth in schizophrenia: a maternal-fetal chronobiological hypothesis. Med Hypothesis 2011;76:785–93.
- McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry 2010;67:889–94.
- McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin M, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237–45.
- Crews M, Lally J, Gardner-Sood P, Howes O, Bonaccorso S, Smith S, et al. Vitamin D deficiency in first episode psychosis: a case-control study. Schizoph Res 2013;150:533–7.
- Yüksel RN, Altunsoy N, Tikir B, Külük MC, Unal K, Goka S, et al. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharm 2014;4:268–75.
- Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J 2012;14:88–92.
- Evaluatie van de voedingsnormen voor vitamine D [Evaluation of food standards for vitamin D]. The Hague: Health Counsel of the Netherlands; 2012; pp. 38–42. Available at http://www.gezondheidsraad.nl/sites/default/files/201215evaluatievoedingsnormenvitamineD.pdf
- Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 2010;112:1–10.
- https://weerstatistieken.nl/de-bilt/2011/mei
- Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville: US Department of Health, Education and Welfare; 1976, pp. 217–22.